Company Number: 15238564

Analysis Date: 2025-07-20 17:58 UTC

Financial Health Assessment of O'NEILL PLANNING LIMITED (as of 31 December 2024)

---

1. Financial Health Score: B

Explanation:
O'Neill Planning Limited shows a strong equity base and solid net assets relative to its small operational scale, indicating an overall healthy financial position for a newly incorporated company. However, minimal operational data and lack of profit and loss detail limit a full diagnostic, warranting a "B" grade. This reflects a stable but still developing financial health profile.

---

2. Key Vital Signs:

Metric	Value	Interpretation
Company Age	~1 year	Very young company, early stage of business development.
Share Capital	£101	Nominal capital, typical for startup companies.
Fixed Assets (Investments)	£1,030,000	Large investment in subsidiaries or group undertakings, indicating asset backing beyond operations.
Current Assets (Debtors)	£101	Minimal current assets; very low receivables.
Net Current Assets	£101	Positive but very low working capital; cash flow capacity from operations is minimal.
Net Assets / Shareholders' Funds	£1,030,101	Strong net equity, largely due to fixed asset investments rather than operational earnings.
Employee Count	4	Small workforce consistent with micro/small company status.
Account Category	Total Exemption Full	Indicates company meets small company thresholds, simplified reporting.
Audit Status	Exempt / Unaudited	Reflects small size and early stage.

---

3. Diagnosis:

O'Neill Planning Limited's financial "vital signs" reveal a company with a "healthy heart" in terms of net equity and asset base, but with "symptoms of infancy" due to its very recent incorporation and limited trading activity. The substantial fixed asset investment (£1.03m) likely represents ownership interests in subsidiaries or related entities, which is a positive foundation but not yet translated into operational cash flow or profit generation.

The current asset level (debtors) and net current assets are minimal, indicating the company has yet to build meaningful day-to-day liquidity or trading activity. The absence of a profit and loss account limits insight into operational profitability or cash flow health, which is akin to not yet having a full clinical history to assess ongoing health trends.

In short, the company is in its "startup incubation" phase with a strong capital "immune system" but limited operational "muscle" or cash flow "circulation" evident so far.

---

4. Recommendations:

1. Build Operational Cash Flow: Focus on developing revenue-generating activities to improve liquidity and working capital. Healthy cash flow is crucial for operational resilience and growth.

2. Monitor Investment Asset Quality: Regularly assess the value and performance of the fixed asset investments to detect any early signs of impairment or risk that could affect net worth.

3. Prepare Detailed Profit and Loss Reporting: Though currently exempt, consider voluntary preparation of P&L statements for internal review to better diagnose operational performance and plan for sustainable growth.

4. Strengthen Financial Controls: As the company grows, implement robust internal financial controls and reporting to detect any "symptoms" of financial distress early.

5. Plan for Audit Readiness: While exempt now, anticipate future thresholds that may require audit and ensure accounting systems and documentation are audit-ready.

6. Maintain Compliance with Filing Deadlines: Continue timely filing of accounts and confirmation statements to avoid regulatory penalties and maintain corporate health.

---